[
  {
    "eMeasureId": "CMS117v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-57b87bd41468",
    "strata": [
      {
        "description": "Diphtheria, tetanus, and pertussis (DTaP) vaccination\nChildren with any of the following on or before the child’s second birthday meet criteria:\n•\tAt least four DTaP vaccinations, with different dates of service. Do not count a vaccination administered prior to 42 days after birth.\n•\tAnaphylaxis due to the diphtheria, tetanus or pertussis vaccine.\n•\tEncephalitis due to the diphtheria, tetanus or pertussis vaccine.\n\nPoliovirus vaccination (IPV)\nAt least three IPV vaccinations, with different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n\nMeasles, mumps, and rubella vaccination (MMR)\nChildren with either of the following meet criteria:\n•\tAt least one MMR vaccination on or between the child’s first and second birthdays.\n•\tAll of the following anytime on or before the child’s second birthday (on the same or different date of service):\no\tHistory of measles\no\tHistory of mumps\no\tHistory of rubella\n\nHaemophilus influenzae type b vaccination (HiB)\nChildren with either of the following meet criteria on or before the child’s second birthday:\n•\tAt least three HiB vaccinations, with different dates of service. Do not count a vaccination administered prior to 42 days after birth.\n•\tAnaphylaxis due to the HiB vaccine.\n\nHepatitis B\nChildren with any of the following on or before the child’s second birthday meet criteria:\n•\tAt least three hepatitis B vaccinations, with different dates of service.\no\tOne of the three vaccinations can be a newborn hepatitis B vaccination during the eight-day period that begins on the date of birth and ends seven days after the date of birth. For example, if the member’s date of birth is December 1, the newborn hepatitis B vaccination must be on or between December 1 and December 8.\n•\tAnaphylaxis due to the hepatitis B vaccine.\n•\tHistory of hepatitis B illness.\n\nVaricella vaccination (VZV)\nChildren with either of the following meet criteria:\n•\tAt least one VZV vaccination, with a date of service on or between the child’s first and second birthdays.\n•\tHistory of varicella zoster (e.g., chicken pox) illness on or before the child’s second birthday.\n\nPneumococcal Conjugate\nAt least four pneumococcal conjugate vaccinations, with different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n\nHepatitis A\nChildren with either of the following meet criteria:\n•\tAt least one hepatitis A vaccination, with a date of service on or between the child’s first and second birthdays.\n•\tHistory of hepatitis A illness on or before the child’s second birthday.\n\nRotavirus\t\nChildren with any of the following meet criteria:\n•\tAt least two doses of the two-dose rotavirus vaccine on different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n•\tAt least three doses of the three-dose rotavirus vaccine on different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n•\tAt least one dose of the two-dose rotavirus vaccine and at least two doses of the three-dose rotavirus vaccine, all on different dates of service, on or before the child’s second birthday. Do not count a vaccination administered prior to 42 days after birth.\n•\tAnaphylaxis due to the rotavirus vaccine on or before the child’s second birthday.\n\nInfluenza\nAt least two influenza vaccinations, with different dates of service on or before the child’s second birthday. Do not count a vaccination administered prior to 6 months (180 days) after birth.\n•\tOne of the two vaccinations can be an LAIV vaccination administered on the child’s second birthday. Do not count an LAIV vaccination administered before the child’s second birthday.",
        "eMeasureUuids": {
          "initialPopulationUuid": "40CAFBE0-4A13-4D63-A2A8-49CFC65C726F",
          "denominatorUuid": "DB248CBC-3C13-4C3E-A77C-447BF11FDECE",
          "numeratorUuid": "9F6EA4E8-5440-4EEF-8AA7-C99873F6814F",
          "denominatorExclusionUuid": "86DD07DA-8FD6-46EE-ABCC-CFDBC93DC5CC"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS122v11",
    "eMeasureUuid": "2c928085-7b2a-eb52-017b-56761e0218d0",
    "strata": [
      {
        "description": "Patients whose most recent HbA1c level (performed during the measurement period) is >9.0% or is missing, or was not performed during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "03D10A51-45B8-4910-998B-7AA0E9B5B9C8",
          "denominatorUuid": "04DFCA04-73BE-4D53-B178-A978A59FC516",
          "numeratorUuid": "8EDDEC39-361E-41C4-89C0-5223A25F24C6",
          "denominatorExclusionUuid": "E12607B8-2F74-4528-9A0D-EBC9AA6392F8"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS124v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-62320c8a1b95",
    "strata": [
      {
        "description": "Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:\n*  Cervical cytology performed during the measurement period or the two years prior to the measurement period for women who are at least 21 years old at the time of the test\n\n*  Cervical human papillomavirus (HPV) testing performed during the measurement period or the four years prior to the measurement period for women who are 30 years or older at the time of the test",
        "eMeasureUuids": {
          "initialPopulationUuid": "0C07C013-5032-4643-BC28-A4CDAE340F84",
          "denominatorUuid": "3AF858F0-A8E4-4E32-89CC-CC6A4CA8A160",
          "numeratorUuid": "4BD54EB9-78DC-4402-9E2F-55B67A49DB80",
          "denominatorExclusionUuid": "E82D67AB-A1EC-401D-8513-9DC56E5BC05D"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS125v11",
    "eMeasureUuid": "2c928083-7ace-2267-017b-08784ec310e9",
    "strata": [
      {
        "description": "Women with one or more mammograms any time on or between October 1 two years prior to the measurement period and the end of the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "A48F4853-9356-4488-993B-A7AC77956D88",
          "denominatorUuid": "08DD1FEF-A4CB-4E2E-B5FB-3E5269BDEC94",
          "numeratorUuid": "A8B1A06E-C20F-4EAD-8440-1488D329B6D2",
          "denominatorExclusionUuid": "4EA53648-C3F4-47BD-B7C1-3C2BDBAA1991"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS127v11",
    "eMeasureUuid": "2c928083-7ace-2267-017b-131d2090146f",
    "strata": [
      {
        "description": "Patients who received a pneumococcal vaccination on or after their 60th birthday and before the end of the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "0EB0E6A0-F856-4394-B82E-93F962D9007A",
          "denominatorUuid": "B8EAA564-CDD2-4B5C-B0DD-D45E75B0984A",
          "numeratorUuid": "EA8E9231-D842-4983-9CB5-B4557EE3C134",
          "denominatorExclusionUuid": "11E18CBE-3985-4267-BA2C-0B08D155A1B3"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS128v11",
    "eMeasureUuid": "2c928082-7fac-c041-017f-b739e6f205a3",
    "strata": [
      {
        "description": "Patients who have received antidepressant medication for at least 84 days (12 weeks) of continuous treatment beginning on the IPSD through 114 days after the IPSD (115 total days).",
        "eMeasureUuids": {
          "initialPopulationUuid": "36EECED5-7E48-438A-90BD-A8E4F61C4FA4",
          "denominatorUuid": "9FF1C889-2F33-4F6C-9A6A-9AA85FC2DFA9",
          "numeratorUuid": "A773BBD6-E63D-4C8A-AB73-56A13D40DF29",
          "denominatorExclusionUuid": "B0CF2F7E-C6DE-4877-A852-DA4D28FA6B42"
        }
      },
      {
        "description": "Patients who have received antidepressant medications for at least 180 days (6 months) of continuous treatment beginning on the IPSD through 231 days after the IPSD (232 total days).",
        "eMeasureUuids": {
          "initialPopulationUuid": "1FE160DE-7DE6-4033-9328-637B9E5DB5E3",
          "denominatorUuid": "B10AE32C-9FE2-4EDB-915A-B48E64428A3E",
          "numeratorUuid": "7837A042-44BE-468C-96FA-379E753E8585",
          "denominatorExclusionUuid": "1FC4B49E-8A6C-4280-85DC-B821E61CD867"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS129v12",
    "eMeasureUuid": "2c928082-7c31-8117-017c-9eab2d122177",
    "strata": [
      {
        "description": "Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer",
        "eMeasureUuids": {
          "initialPopulationUuid": "9E5FAD32-CC2C-4AC6-9197-7CCB783BE8AE",
          "denominatorUuid": "E38B1D66-1478-4C8D-9233-D93C688EB19C",
          "numeratorUuid": "D19D8FE2-74BD-4E08-8CA4-ACAD01D99FA0",
          "denominatorExceptionUuid": "C011B70B-1937-45DE-9FF9-F92A1D2C747B"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS130v11",
    "eMeasureUuid": "2c928083-7ace-2267-017b-11fbb9c913c4",
    "strata": [
      {
        "description": "Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: \n- Fecal occult blood test (FOBT) during the measurement period\n- FIT-DNA during the measurement period or the two years prior to the measurement period\n- Flexible sigmoidoscopy during the measurement period or the four years prior to the measurement period\n- CT Colonography during the measurement period or the four years prior to the measurement period\n- Colonoscopy during the measurement period or the nine years prior to the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "47C22A0B-B173-42C3-9A76-6EF551051048",
          "denominatorUuid": "DE26733F-B5DB-489C-B8AB-2E89F45EFEA6",
          "numeratorUuid": "C4A832B5-9074-4062-B462-7AF0BF76941D",
          "denominatorExclusionUuid": "81A9AB85-0495-450F-AE89-528348C291DB"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS131v11",
    "eMeasureUuid": "2c928085-7b2a-eb52-017b-55383a9c16e3",
    "strata": [
      {
        "description": "Patients with an eye screening for diabetic retinal disease. This includes diabetics who had one of the following:\n•Diabetic with a diagnosis of retinopathy in any part of the measurement period and a retinal or dilated eye exam by an eye care professional in the measurement period\n•Diabetic with no diagnosis of retinopathy in any part of the measurement period and a retinal or dilated eye exam by an eye care professional in the measurement period or the year prior to the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "0C11F942-5E5C-43E3-8707-E8B799CA09B5",
          "denominatorUuid": "E759F9A4-87DB-47AB-808E-BF9E99F960CF",
          "numeratorUuid": "D1C773EF-4566-4DE0-A63B-DAC54A9195AC",
          "denominatorExclusionUuid": "7B14535D-E733-43A5-9E4D-2B521CFFDAF1"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS133v11",
    "eMeasureUuid": "2c928082-7c31-8117-017c-9e70f76c20e0",
    "strata": [
      {
        "description": "Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery",
        "eMeasureUuids": {
          "initialPopulationUuid": "CAB587F6-B090-4CF5-8AE7-3038ABE52D87",
          "denominatorUuid": "5ECB1287-6980-4884-90CC-3A1EF81BD65E",
          "numeratorUuid": "4C4097A8-35FC-49ED-8001-756C4F430955",
          "denominatorExclusionUuid": "5460C192-D956-4B8C-932B-9E87EBD446AF"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS135v11",
    "eMeasureUuid": "2c928083-7f47-c81f-017f-8e47bb0b1def",
    "strata": [
      {
        "description": "Patients who were prescribed or already taking ACE inhibitor or ARB or ARNI therapy during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "D04B994C-8901-4630-A23B-50C2EAE27433",
          "denominatorUuid": "5EB41241-EA99-4FCB-85BF-44E0509E7E1D",
          "numeratorUuid": "A5F82AF1-81B0-4D44-BB63-BBE3EEDD1B31",
          "denominatorExceptionUuid": "4A0024CC-2DE3-4C16-92D9-7114841081F4",
          "denominatorExclusionUuid": "EE6A72E2-BD92-44CF-B0B2-F3484F14BFE7"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS136v12",
    "eMeasureUuid": "2c928082-7b1b-ab09-017b-28e8655e02f2",
    "strata": [
      {
        "description": "Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase.",
        "eMeasureUuids": {
          "initialPopulationUuid": "D79D2A15-C472-4AC1-A2FD-E2E335A6F316",
          "denominatorUuid": "97564B2A-C7DE-4F48-B960-46E1940FE6D6",
          "numeratorUuid": "6B82B99D-30A6-4CB9-9F89-0FA0B6A8BA62",
          "denominatorExclusionUuid": "FF603917-BC11-4B77-9DD7-6BC14409125B"
        }
      },
      {
        "description": "Patients who had at least one visit with a practitioner with prescribing authority during the Initiation Phase, and at least two follow-up visits during the 31-300 days after the IPSD.",
        "eMeasureUuids": {
          "initialPopulationUuid": "1FA8F15B-541A-4179-96DF-37E4EE78B399",
          "denominatorUuid": "17DB3927-8710-4D08-AF5E-40932359545C",
          "numeratorUuid": "19D8848F-994D-4B53-8370-95CE18435143",
          "denominatorExclusionUuid": "103358A7-124C-4D76-932D-CBD267CD6A36"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS137v11",
    "eMeasureUuid": "2c928083-7ace-2267-017a-f40a7dc90d17",
    "strata": [
      {
        "description": "Initiation of treatment includes either an intervention or medication for the treatment of SUD within 14 days of the new SUD episode",
        "eMeasureUuids": {
          "initialPopulationUuid": "5B283FB2-0BB1-40AF-9DEB-854756C123C9",
          "denominatorUuid": "33A99C2B-9DCB-4871-9A55-58DE0C9BC7FD",
          "numeratorUuid": "DD4D8959-0D99-4B37-AFEE-39C817C06382",
          "denominatorExclusionUuid": "808455B9-0E89-48C9-890E-4CEFF04DF04D"
        }
      },
      {
        "description": "Engagement in ongoing SUD treatment within 34 days of initiation includes:",
        "eMeasureUuids": {
          "initialPopulationUuid": "738B0565-B607-432C-B5AE-55F6793893E2",
          "denominatorUuid": "E15A81D8-C7A1-4F8B-86A0-6A3D32746A2F",
          "numeratorUuid": "1C22603B-A4BC-49C2-B49F-2AD228B61648",
          "denominatorExclusionUuid": "072AF1FD-CB10-4D6B-8E32-5A23845E25AE"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS138v11",
    "eMeasureUuid": "2c928085-7b2a-eb52-017b-5fbdf0ce2068",
    "strata": [
      {
        "description": "Patients who were screened for tobacco use at least once during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "908AE77A-2E96-4BBA-89C1-8974F28F7DF1",
          "denominatorUuid": "4A8586D1-0CD3-43CA-BFB3-A7089E65EA16",
          "numeratorUuid": "55EAE4F4-F97D-4574-9AA6-66E92D210465",
          "denominatorExclusionUuid": "56A0A788-68BF-4CED-BA2E-4E6B62E9F3E0"
        }
      },
      {
        "description": " Patients who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "7C477BC5-C75B-4B7C-B061-A61CEC7E821B",
          "denominatorUuid": "21377D57-D5CC-4599-9DFE-2C989AFAAD1E",
          "numeratorUuid": "1434049B-C8C7-41F2-8454-212F248527E6",
          "denominatorExclusionUuid": "6317874C-E95E-4230-A3DA-D65D00C1644F"
        }
      },
      {
        "description": "Patients who were screened for tobacco use at least once during the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as a tobacco user",
        "eMeasureUuids": {
          "initialPopulationUuid": "124F09CB-F6BB-4717-BC04-49E5C1CE52B2",
          "denominatorUuid": "1764C19B-A8EE-41A0-A384-93B5371CE650",
          "numeratorUuid": "D72761CF-7D10-471A-A89C-461892FE8BD6",
          "denominatorExclusionUuid": "F6CB55D6-D6ED-4471-88C7-9B7C9C34B060"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS139v11",
    "eMeasureUuid": "2c928085-7b2a-eb52-017b-5a3c9e801a0e",
    "strata": [
      {
        "description": "Patients who were screened for future fall risk at least once within the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "1BDDA0B0-E542-42CF-B9C5-1BD7C782011C",
          "denominatorUuid": "AFE4195D-82A8-477E-9298-2957BB765BCD",
          "numeratorUuid": "78D02793-D659-450F-BB79-016718F7B3FD",
          "denominatorExclusionUuid": "FBA4B283-50BC-4D6B-AC35-EF7C907BA8D2"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS142v11",
    "eMeasureUuid": "2c928082-7c31-8117-017c-a3bc7c842491",
    "strata": [
      {
        "description": "Patients with documentation, at least once within 12 months, of the findings of the dilated macular or fundus exam via communication to the physician who manages the patient's diabetic care",
        "eMeasureUuids": {
          "initialPopulationUuid": "E1C52911-4CF0-4D47-AF14-0DC3BEE657AA",
          "denominatorUuid": "B3C7A77A-1620-43E6-B1BB-82CE0798DF07",
          "numeratorUuid": "C1BBE3BB-D0D4-43A2-A376-62C6A76E4FC4",
          "denominatorExceptionUuid": "F5A57901-16EE-4072-938D-C2049D6F1CC5"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS143v11",
    "eMeasureUuid": "2c928082-7c31-8117-017c-dc62175a32d0",
    "strata": [
      {
        "description": "Patients who have an optic nerve head evaluation during one or more visits within 12 months",
        "eMeasureUuids": {
          "initialPopulationUuid": "C6C5C5BB-317D-4A0E-8C01-8A6AD32A14CC",
          "denominatorUuid": "4C7DC8F0-6185-4066-BF81-7C69F7A01E02",
          "numeratorUuid": "ED247AFB-B3D5-4CB9-9381-771B30CC57B4",
          "denominatorExceptionUuid": "66ED4D4A-0D11-46A4-B928-583A2955E40C"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS144v11",
    "eMeasureUuid": "2c928083-7f47-c81f-017f-94e80ecd219f",
    "strata": [
      {
        "description": "Patients who were prescribed or already taking beta-blocker therapy during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "38B794DC-FC92-45C3-869C-4027BBD1B227",
          "denominatorUuid": "60CECE68-709E-4A13-9CA9-357D5A4591DF",
          "numeratorUuid": "F7743DA5-9C92-4ACD-A83F-55EE47A79BAC",
          "denominatorExceptionUuid": "886E5B46-D652-4A03-84A3-92C1D65DDA64",
          "denominatorExclusionUuid": "6C20AA4B-12AE-4317-B863-41AAFFB5B6D2"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS146v11",
    "eMeasureUuid": "2c928082-7fac-c041-0180-00070b9d19b8",
    "strata": [
      {
        "description": "A group A streptococcus test in the seven-day period from three days prior to the episode date through three days after the episode date",
        "eMeasureUuids": {
          "initialPopulationUuid": "4BDD5540-AFC4-4CA3-8329-A807EED53443",
          "denominatorUuid": "E4C56163-E195-4151-9D63-C47EBFD51240",
          "numeratorUuid": "531399EF-9F6E-41B8-AD35-40C33FC1049E",
          "denominatorExclusionUuid": "E15EFFEB-F70A-4898-94C3-B202965621AB"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS147v12",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-4b7d5aea1247",
    "strata": [
      {
        "description": "Patients who received an influenza immunization OR who reported previous receipt of an influenza immunization between July 1 of the year prior to the measurement period to June 30 of the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "633BC4B8-F7B1-4894-898A-4B28354F020B",
          "denominatorUuid": "86BADCD8-40F2-4DE6-869E-8D070BCD836B",
          "numeratorUuid": "DE0CFE85-9842-4441-96C2-66FDFD832854",
          "denominatorExclusionUuid": "35A091F0-2AC6-44DD-B7B2-754372A69B93"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS149v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-5d9c93c61797",
    "strata": [
      {
        "description": "Patients for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period",
        "eMeasureUuids": {
          "initialPopulationUuid": "B131923B-75CF-4D85-B4C9-FD412CC0036D",
          "denominatorUuid": "530B1477-EEA8-4383-AE24-06062643583B",
          "numeratorUuid": "FCA90502-9BED-48C7-B08F-F0719338ACCE",
          "denominatorExceptionUuid": "4BADB805-F737-4423-8DC3-DDDCF071244F"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS153v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-a185ed852f11",
    "strata": [
      {
        "description": "Women with at least one chlamydia test during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "8C114CFB-77B8-483E-B557-5798117AA0D2",
          "denominatorUuid": "DD94450E-004B-4FCB-BA3B-2B6052916921",
          "numeratorUuid": "DA23B2AF-A0BF-4D9B-9727-511E9EAB55EE",
          "denominatorExclusionUuid": "3D0BE476-5E5A-4DDE-83CC-C92D1BF6674B"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS154v11",
    "eMeasureUuid": "2c928084-7b7e-655a-017b-836f26940269",
    "strata": [
      {
        "description": "URI episodes without a prescription for antibiotic medication on or 3 days after the outpatient visit, telephone visit, online assessment, observation stay or emergency department visit for an upper respiratory infection",
        "eMeasureUuids": {
          "initialPopulationUuid": "25AC97CF-C363-4AB2-A33C-B955EB1B1880",
          "denominatorUuid": "FF6F5C7E-0F8F-4816-93A9-2F9346ABCE6A",
          "numeratorUuid": "B0A705C3-C23D-4024-8B87-4CB94139D2DA",
          "denominatorExclusionUuid": "2074C3BD-C128-41BC-9EB2-7ED9D8F4071E"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS155v11",
    "eMeasureUuid": "2c928085-7b2a-eb52-017b-6454f275227c",
    "strata": [
      {
        "description": "Patients who had a height, weight and body mass index (BMI) percentile recorded during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "022FA42B-5795-46AE-B9BF-41889422BB2F",
          "denominatorUuid": "026EBFBE-331F-4D24-8FB9-6051D7E65986",
          "numeratorUuid": "D85CCDD7-6FC4-4F82-BC73-D8F09CB90BCC",
          "denominatorExclusionUuid": "93806F6A-9D3D-45B7-A4C7-EA53D7B01605"
        }
      },
      {
        "description": "Patients who had counseling for nutrition during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "E53C7357-376A-4CF7-833C-F2481CCE3F90",
          "denominatorUuid": "0D92825D-6BB9-41C1-B082-D5F1953C5C47",
          "numeratorUuid": "2B1AF1D8-54D1-4460-9957-1D575042D9E6",
          "denominatorExclusionUuid": "103852A1-6CDC-4D87-89AB-488B2CD6C9BB"
        }
      },
      {
        "description": "Patients who had counseling for physical activity during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "FA81E5FE-F51D-4615-A462-085A98930B4D",
          "denominatorUuid": "F9C718C5-ECA3-49EA-AA6A-D737D1B1B483",
          "numeratorUuid": "2EFA20D0-B664-4773-AD46-95A8DB373284",
          "denominatorExclusionUuid": "4970EF2B-C450-43F7-8DDC-796247C19D6B"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS156v11",
    "eMeasureUuid": "2c928084-808a-9589-0180-d74bf7b7164d",
    "strata": [
      {
        "description": "Rate 1: Patients with at least two orders of high-risk medications from the same drug class on different days.",
        "eMeasureUuids": {
          "initialPopulationUuid": "064940DC-3F04-4B31-88CA-367BE20AC510",
          "denominatorUuid": "CD3CCAD3-3E90-4094-9987-9A9D2A5D574D",
          "numeratorUuid": "E384D9B0-6AD6-45BC-B562-A57E46FC1E90",
          "denominatorExclusionUuid": "CEC58D2D-4525-45B8-B320-FFB35B654DA8"
        }
      },
      {
        "description": "a. At least two orders of high-risk medications from the same drug class.",
        "eMeasureUuids": {
          "initialPopulationUuid": "5E28FE53-02D9-4A14-9721-74729FBF2F73",
          "denominatorUuid": "5BE6C6E2-64FA-49D5-8D2E-B977E2AB62A7",
          "numeratorUuid": "5577FDAE-5153-4B75-9B85-59CEF09CFC82",
          "denominatorExclusionUuid": "82D62AA5-015B-4256-AF2B-C43D52622EFB"
        }
      },
      {
        "description": "b. At least two orders of high-risk medications from the same drug class with summed days supply greater than 90 days.",
        "eMeasureUuids": {
          "initialPopulationUuid": "2B4CFB1B-43D2-4ABA-AE55-CCF174208A3B",
          "denominatorUuid": "725E725B-DF32-429A-BAEE-444AD4CE5FC7",
          "numeratorUuid": "35C1118F-EBF8-470F-8B70-150CB04435AA",
          "denominatorExclusionUuid": "AEA06864-DA4F-4ECD-93EC-BA6B94930337"
        }
      },
      {
        "description": "c. At least two orders of high-risk medications from the same drug class each exceeding average daily dose criteria."
      },
      {
        "description": "Rate 2: Patients with at least two orders of high-risk medications from the same drug class (i.e., antipsychotics and benzodiazepines) on different days."
      },
      {
        "description": "Total rate (the sum of the two previous numerators, deduplicated)."
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS159v11",
    "eMeasureUuid": "2c928082-7fac-c041-017f-aee6377002a5",
    "strata": [
      {
        "description": "Adolescent patients 12 to 17 years of age and adult patients 18 years of age and older who achieved remission at twelve months as demonstrated by the most recent twelve month (+/- 60 days) PHQ-9 or PHQ-9M score of less than five",
        "eMeasureUuids": {
          "initialPopulationUuid": "E9A0337E-6F37-434B-BA79-27A275C8AED2",
          "denominatorUuid": "12EBE340-3CC4-4903-8C89-A64C1224E3C5",
          "numeratorUuid": "7783900A-FCDA-4105-ACA7-CE0A5B44D9B1",
          "denominatorExclusionUuid": "79853866-D964-400A-BB54-D96369498CBD"
        }
      }
    ],
    "metricType": "multiPerformanceRate"
  },
  {
    "eMeasureId": "CMS161v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-5d428e9516ff",
    "strata": [
      {
        "description": "Patient visits during which a new diagnosis of MDD, single or recurrent episode, was identified and a suicide risk assessment was completed during the visit",
        "eMeasureUuids": {
          "initialPopulationUuid": "DC8E1A1C-BD9E-4F8E-8584-388BECBEF0E8",
          "denominatorUuid": "2B4E018E-7F6A-4C15-AD7B-AECABB45D4A7",
          "numeratorUuid": "D732F43D-14F0-44C4-B59E-EB48BA469080"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS165v11",
    "eMeasureUuid": "2c928082-7a14-d92c-017a-67b6f9971ea8",
    "strata": [
      {
        "description": "Patients whose most recent blood pressure is adequately controlled (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "EB3E42F6-9774-4066-8CA8-4329C95E4541",
          "denominatorUuid": "66167A47-3FD1-4E48-A51F-750ED6FF9147",
          "numeratorUuid": "FDF9F696-67F2-4AE6-953C-5DDE27BB93E7",
          "denominatorExclusionUuid": "CD4A4AD6-3C0B-4D7B-9751-F1A9268DF402"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS177v11",
    "eMeasureUuid": "2c928082-7ce1-6f5f-017d-002cb9ae0a21",
    "strata": [
      {
        "description": "Patient visits with an assessment for suicide risk",
        "eMeasureUuids": {
          "initialPopulationUuid": "EBA79DD6-1BD3-469D-958E-E042A45EF669",
          "denominatorUuid": "F6049FD1-E4CD-48B2-934B-DB15D0EDB2D2",
          "numeratorUuid": "F162147A-980C-4633-BE57-09894AFF420A"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS22v11",
    "eMeasureUuid": "2c928083-7bc5-ed6e-017b-c6c6dd050158",
    "strata": [
      {
        "description": "Patient visits where patients were screened for high blood pressure AND have a recommended follow-up plan documented, as indicated, if the blood pressure is elevated or hypertensive",
        "eMeasureUuids": {
          "initialPopulationUuid": "2FCF6574-DA49-4EFE-8AF2-EEEF66A6991B",
          "denominatorUuid": "FEAFF2AA-A45F-4EE5-BB4A-B920C13F63CB",
          "numeratorUuid": "CC44A071-CADC-414C-A55C-574E04A1E414",
          "denominatorExceptionUuid": "DF696C0F-8D01-4A4C-B00F-E1A2C59B9358",
          "denominatorExclusionUuid": "4EA871D1-4D5A-4347-9F69-B50C7E03381A"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS249v5",
    "eMeasureUuid": "2c928082-7ac4-569d-017a-ca2f0fa10205",
    "strata": [
      {
        "description": "Female patients who received an order for at least one DXA scan in the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "4B34F4ED-1A49-4A8B-87E8-FABF70962F2B",
          "denominatorUuid": "A89FF41B-8F0B-486D-A640-945054FB9CA4",
          "numeratorUuid": "C86B7AF8-F152-478F-8CFC-ACCC0D4BA376",
          "denominatorExclusionUuid": "1865BCB7-B020-4329-A3B7-7AEA32E0AC81"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS2v12",
    "eMeasureUuid": "2c928082-7ce1-6f5f-017c-e6532e90030c",
    "strata": [
      {
        "description": "Patients screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized tool AND if positive, a follow-up plan is documented on the date of or up to two days after the date of the qualifying encounter",
        "eMeasureUuids": {
          "initialPopulationUuid": "B28864C4-1674-4476-879C-08E620CB7E56",
          "denominatorUuid": "77F28681-11EB-4BFF-98C8-E68823820AF1",
          "numeratorUuid": "058B20CD-119E-40C6-9431-A383022AD65C",
          "denominatorExceptionUuid": "4DAA814C-005B-4B38-A9B4-980A0BE45EF3",
          "denominatorExclusionUuid": "87A2CE58-EFD2-407A-B771-BE0BEADD8C00"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS349v5",
    "eMeasureUuid": "2c928082-79c7-5ccc-0179-e7314f850909",
    "strata": [
      {
        "description": "Patients with documentation of an HIV test performed on or after their 15th birthday and before their 66th birthday",
        "eMeasureUuids": {
          "initialPopulationUuid": "9129F55B-3A36-4E46-8438-03118FBBE8F3",
          "denominatorUuid": "19B8D19D-369E-4E2D-9C1A-720EB41EEB90",
          "numeratorUuid": "93B7A884-9D74-45B7-9FA5-F980DC3A46E9",
          "denominatorExclusionUuid": "0C0B2EE5-4412-4DA4-AA7B-F95184A5DAE6"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS50v11",
    "eMeasureUuid": "2c928083-7f47-c81f-017f-9db2b740245f",
    "strata": [
      {
        "description": "Number of patients with a referral on or before October 31, for which the referring clinician received a report from the clinician to whom the patient was referred",
        "eMeasureUuids": {
          "initialPopulationUuid": "5934B847-B849-4BC7-B056-D37A55BA75B2",
          "denominatorUuid": "CACBED63-74BE-4453-B6F0-0CA81D02BEAD",
          "numeratorUuid": "9245BBE0-2CC5-4FE7-A9A3-052B2D1F0B70"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS56v11",
    "eMeasureUuid": "2c928082-7b1b-ab09-017b-1ccd947501b8",
    "strata": [
      {
        "description": "Patients with patient-reported functional status assessment results (i.e., Veterans RAND 12-item health survey [VR-12], Patient-Reported Outcomes Measurement Information System [PROMIS]-10-Global Health, Hip Disability and Osteoarthritis Outcome Score [HOOS], HOOS Jr.) in the 90 days prior to or on the day of the primary THA procedure, and in the 270 - 365 days after the THA procedure",
        "eMeasureUuids": {
          "initialPopulationUuid": "677EE12F-32FB-4A26-92D7-AEA238510E2B",
          "denominatorUuid": "51D9A3CF-A17A-480A-AFAA-FB9C0483B90C",
          "numeratorUuid": "FB569C9B-9CBE-4524-AA03-1816F0C22683",
          "denominatorExclusionUuid": "C988AD35-D2AE-4430-AC37-0E87A216FAA2"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS645v6",
    "eMeasureUuid": "2c928082-7d0a-17c1-017d-0a2f702d00a4",
    "strata": [
      {
        "description": "Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment",
        "eMeasureUuids": {
          "initialPopulationUuid": "A63A2F2D-81BC-4905-800A-195FC31797FE",
          "denominatorUuid": "7723BDB0-95DB-4430-A1A1-8B164E777E88",
          "numeratorUuid": "5EC744C6-2ABB-4E81-AEEC-6310E081EDC9",
          "denominatorExceptionUuid": "2091C83F-1866-4797-9858-877986C576F7"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS646v3",
    "eMeasureUuid": "2c928082-7c03-4632-017c-0abd21c10652",
    "strata": [
      {
        "description": "Intravesical Bacillus-Calmette Guerin (BCG) instillation for initial dose or series\nBCG is initiated within 6 months of the bladder cancer staging and during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "95B76369-3ABF-4B4C-A38C-3D1A2EE8542F",
          "denominatorUuid": "64A8D4B0-6DB2-451A-A122-DF9ABDC89361",
          "numeratorUuid": "72AE0569-F012-47E9-99E4-96B375EA92C6",
          "denominatorExceptionUuid": "56B0D839-6F91-47AA-95D2-EB0E32018D1D",
          "denominatorExclusionUuid": "2811837F-59F8-4EB5-A580-F2A88D3B74D5"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS68v12",
    "eMeasureUuid": "2c928082-7c31-8117-017c-9eacd82c2183",
    "strata": [
      {
        "description": "Eligible clinician attests to documenting, updating, or reviewing the patient's current medications using all immediate resources available on the date of the encounter",
        "eMeasureUuids": {
          "initialPopulationUuid": "972EBD00-B885-4E74-8033-B2F14671CCEF",
          "denominatorUuid": "1959AB01-1DAF-4D59-94C9-D11DE2F515C9",
          "numeratorUuid": "5E7C9BEE-CC15-42B5-A34E-F8D813CD303E",
          "denominatorExceptionUuid": "65C83FE7-CFAE-4CDE-B49D-6C78D5D780C5"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS69v11",
    "eMeasureUuid": "2c928082-7fac-c041-017f-b3038b3e0469",
    "strata": [
      {
        "description": "Patients with a documented BMI during the encounter or during the measurement period, AND when the BMI is outside of normal parameters, a follow-up plan is documented during the encounter or during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "ECEB0BD8-FF04-4ECE-8674-0AF4A3FB5CA9",
          "denominatorUuid": "FAB66FEA-6008-423B-A3C2-FBE727361CC3",
          "numeratorUuid": "9B735D8D-3813-4887-A324-9F6B48BDC63C",
          "denominatorExceptionUuid": "19CB93F3-2532-4C7D-BC60-593589929D89",
          "denominatorExclusionUuid": "49AC7D10-7463-431E-BDA6-D934E841F426"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS74v12",
    "eMeasureUuid": "2c928082-7b1b-ab09-017b-1cce1c2e01ca",
    "strata": [
      {
        "description": "Children who receive a fluoride varnish application during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "CDCB2DA5-1BDB-43F7-BC36-20747CB28F7C",
          "denominatorUuid": "76B1094E-2658-4FA5-A954-EA2507B4696B",
          "numeratorUuid": "4146BCB6-11FE-4DAA-9686-3BF8F46A3B18",
          "denominatorExclusionUuid": "A014A5FB-BC16-4DFD-8FFB-4899C567FAB2"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS75v11",
    "eMeasureUuid": "2c928082-7b1b-ab09-017b-1cce6f5f01d2",
    "strata": [
      {
        "description": "Children who had a diagnosis of cavities or decayed teeth in any part of the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "B82CFAA4-651D-471A-9A6D-F488C440C4B5",
          "denominatorUuid": "0DECD61D-147D-491C-B47D-FD484FC54FD5",
          "numeratorUuid": "48FF19CE-EC28-4A1A-B5E4-1603A1459218",
          "denominatorExclusionUuid": "A4F09B0F-C613-45B2-811E-20117ACEE641"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS771v4",
    "eMeasureUuid": "2c928082-7c03-4632-017c-0abc66830646",
    "strata": [
      {
        "description": "Patients with a documented improvement of at least 3 points in their urinary symptom score during the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "33C1803E-173C-41AD-8702-BF3125CA7BF4",
          "denominatorUuid": "9B79D949-EF45-4C97-BBE6-0475B9703D09",
          "numeratorUuid": "792A9413-98A5-4DA6-92F0-20F7AB5E16F7",
          "denominatorExclusionUuid": "2A6FC813-F5D2-4454-B317-339FF6DDE9D1"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS90v12",
    "eMeasureUuid": "2c928082-7fac-c041-017f-e1110496119a",
    "strata": [
      {
        "description": "Patients with patient-reported functional status assessment results (i.e., Veterans RAND 12-item health survey [VR-12]; VR-36; Kansas City Cardiomyopathy Questionnaire [KCCQ]; KCCQ-12; Minnesota Living with Heart Failure Questionnaire [MLHFQ]; Patient-Reported Outcomes Measurement Information System [PROMIS]-10 Global Health, PROMIS-29) present in the EHR within two weeks before or during the initial FSA encounter and results for the follow-up FSA at least 30 days but no more than 180 days after the initial FSA",
        "eMeasureUuids": {
          "initialPopulationUuid": "2FD2D5BD-5766-427F-9DE7-F0C4FD319A86",
          "denominatorUuid": "DD21E3D1-8F5B-41EE-878A-4F4E77AE684A",
          "numeratorUuid": "A01BF233-7E85-4D00-9866-FD2C245F2A3F",
          "denominatorExclusionUuid": "693817B3-25B9-4990-9526-C4B559E7EDDF"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  },
  {
    "eMeasureId": "CMS951v1",
    "eMeasureUuid": "2c928082-7fac-c041-017f-acf430150098",
    "strata": [
      {
        "description": "Patients who received a kidney health evaluation defined by an Estimated Glomerular Filtration Rate (eGFR) AND Urine Albumin-Creatinine Ratio (uACR) within the measurement period",
        "eMeasureUuids": {
          "initialPopulationUuid": "E6F8706C-A37F-4316-97DE-563920A577F4",
          "denominatorUuid": "8545B038-5C37-4C75-A8E1-6015570C6401",
          "numeratorUuid": "75280F69-71E2-4FA3-8028-1F7C62199378",
          "denominatorExclusionUuid": "188420E4-AA19-496E-ADE1-543AED6F00EB"
        }
      }
    ],
    "metricType": "singlePerformanceRate"
  }
]